MX2010002994A - Dominios de fijacion del ligando de receptores nucleares en forma controlable y metodos que conllevan los mismos. - Google Patents
Dominios de fijacion del ligando de receptores nucleares en forma controlable y metodos que conllevan los mismos.Info
- Publication number
- MX2010002994A MX2010002994A MX2010002994A MX2010002994A MX2010002994A MX 2010002994 A MX2010002994 A MX 2010002994A MX 2010002994 A MX2010002994 A MX 2010002994A MX 2010002994 A MX2010002994 A MX 2010002994A MX 2010002994 A MX2010002994 A MX 2010002994A
- Authority
- MX
- Mexico
- Prior art keywords
- same
- ligand binding
- binding domains
- methods involving
- nuclear receptors
- Prior art date
Links
- 108020005497 Nuclear hormone receptor Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 102000006255 nuclear receptors Human genes 0.000 title abstract 3
- 108020004017 nuclear receptors Proteins 0.000 title abstract 3
- 108020001756 ligand binding domains Proteins 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- High Energy & Nuclear Physics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente invenci?n se refiere a una prote?na aislada que comprende un dominio de fijaci?n del ligando de un receptor nuclear en forma controlable, a un m?todo de producci?n del mismo, a su uso para la identificaci?n de un ligando, a un sistema anal?tico que comprende la prote?na aislada y a un m?todo para identificar un ligando por un receptor nuclear utilizando el sistema anal?tico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07291163A EP2042515A1 (en) | 2007-09-27 | 2007-09-27 | Ligand binding domains of nuclear receptors in controllable form and methods involving the same |
| PCT/EP2008/007596 WO2009040003A1 (en) | 2007-09-27 | 2008-09-13 | Ligand binding domains of nuclear receptors in controllable form and methods involving the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010002994A true MX2010002994A (es) | 2010-04-01 |
Family
ID=38738943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010002994A MX2010002994A (es) | 2007-09-27 | 2008-09-13 | Dominios de fijacion del ligando de receptores nucleares en forma controlable y metodos que conllevan los mismos. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20110177611A1 (es) |
| EP (2) | EP2042515A1 (es) |
| JP (1) | JP2010540474A (es) |
| KR (1) | KR20100075856A (es) |
| CN (1) | CN101809031A (es) |
| AR (1) | AR068549A1 (es) |
| AU (1) | AU2008303867B2 (es) |
| CA (1) | CA2700725A1 (es) |
| IL (1) | IL204667A0 (es) |
| MX (1) | MX2010002994A (es) |
| SG (1) | SG185258A1 (es) |
| TW (1) | TW200931020A (es) |
| WO (1) | WO2009040003A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2181710A1 (en) * | 2008-10-28 | 2010-05-05 | Phenex Pharmaceuticals AG | Ligands for modulation of orphan receptor-gamma (NR1F3) activity |
| US8574862B2 (en) * | 2009-05-06 | 2013-11-05 | Cytochrama Inc. | Methods and composition for measuring the amount of Vitamin D derivatives |
| WO2011019556A1 (en) | 2009-08-11 | 2011-02-17 | Janssen Pharmaceutica Nv | CO-CRYSTALLIZATION OF ERR-A α WITH A LIGAND THAT FORMS A REVERSIBLE CONVALENT BOND |
| CN102262158A (zh) * | 2010-05-27 | 2011-11-30 | 戴国祯 | 重组融合蛋白质在快速诊断检测中的直接应用 |
| US20140017260A1 (en) * | 2012-07-16 | 2014-01-16 | Mayo Foundation For Medical Education And Research | Methods and materials for reducing bone loss |
| US12139515B2 (en) * | 2018-10-29 | 2024-11-12 | Agricultural Technology Research Institute | Dextran affinity tag and use thereof |
| CN113461809A (zh) * | 2020-07-17 | 2021-10-01 | 南京诺唯赞生物科技股份有限公司 | 筛选结合抑制剂和/或结合区域的方法 |
| CN115356320B (zh) * | 2022-10-20 | 2023-01-17 | 上海诚益生物科技有限公司 | 基于均相时间分辨荧光技术的体外rig-i激活检测的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2446218A1 (en) * | 2001-05-07 | 2003-01-03 | Centre National De La Recherche Scientifique | Polypeptides derived from retinoic acid-related orphan receptor (ror),and their applications |
| EP1501867A1 (en) * | 2002-04-29 | 2005-02-02 | Novartis AG | Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha) |
| US20050048539A1 (en) * | 2003-06-13 | 2005-03-03 | The General Hospital Corporation | Methods to monitor molecule conformation and molecule/molecule proximity |
| ATE459721T1 (de) * | 2005-12-22 | 2010-03-15 | Indanio Bioscience Inc | Verfahren und zusammensetzungen für den nachweis bzw. die isolation von liganden |
-
2007
- 2007-09-27 EP EP07291163A patent/EP2042515A1/en not_active Ceased
-
2008
- 2008-09-13 WO PCT/EP2008/007596 patent/WO2009040003A1/en not_active Ceased
- 2008-09-13 KR KR1020107006453A patent/KR20100075856A/ko not_active Ceased
- 2008-09-13 CA CA2700725A patent/CA2700725A1/en not_active Abandoned
- 2008-09-13 SG SG2012071916A patent/SG185258A1/en unknown
- 2008-09-13 CN CN200880108831A patent/CN101809031A/zh active Pending
- 2008-09-13 JP JP2010526185A patent/JP2010540474A/ja active Pending
- 2008-09-13 MX MX2010002994A patent/MX2010002994A/es active IP Right Grant
- 2008-09-13 AU AU2008303867A patent/AU2008303867B2/en not_active Ceased
- 2008-09-13 EP EP08802147.2A patent/EP2195334B1/en active Active
- 2008-09-13 US US12/675,804 patent/US20110177611A1/en not_active Abandoned
- 2008-09-25 AR ARP080104166A patent/AR068549A1/es not_active Application Discontinuation
- 2008-09-25 TW TW097136778A patent/TW200931020A/zh unknown
-
2010
- 2010-03-22 IL IL204667A patent/IL204667A0/en unknown
-
2012
- 2012-07-17 US US13/550,865 patent/US20120282710A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2195334A1 (en) | 2010-06-16 |
| TW200931020A (en) | 2009-07-16 |
| EP2042515A1 (en) | 2009-04-01 |
| US20110177611A1 (en) | 2011-07-21 |
| CN101809031A (zh) | 2010-08-18 |
| JP2010540474A (ja) | 2010-12-24 |
| US20120282710A1 (en) | 2012-11-08 |
| WO2009040003A1 (en) | 2009-04-02 |
| EP2195334B1 (en) | 2013-07-31 |
| SG185258A1 (en) | 2012-11-29 |
| AU2008303867A1 (en) | 2009-04-02 |
| IL204667A0 (en) | 2010-11-30 |
| AU2008303867B2 (en) | 2013-05-16 |
| KR20100075856A (ko) | 2010-07-05 |
| AR068549A1 (es) | 2009-11-18 |
| CA2700725A1 (en) | 2009-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010002994A (es) | Dominios de fijacion del ligando de receptores nucleares en forma controlable y metodos que conllevan los mismos. | |
| GB2464027B (en) | Methods and apparatuses for formation tester data processing | |
| PH12012502193A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies | |
| GB201014774D0 (en) | System and method for well test design, interpretation and test objectives verification | |
| IL197459A0 (en) | Humanized proteins, including antibodies and methods for producing the same | |
| ZA201103152B (en) | Modified apparatus and method for assessment,evaluation,evaluation and grading of gemstones | |
| TN2011000433A1 (en) | Alpha -4-beta-7heterodimer specific antagonist antibody | |
| MX2009008104A (es) | Hepcidina, antagonistas de hepcidina y metodos de uso. | |
| GB2460170B (en) | Apparatus and methods for subsea control system testing | |
| GB2476199B (en) | Method and apparatus for non-destructive testing | |
| IL208204A0 (en) | Her2/neu-specific antibodies and methods of using same | |
| IL184167A0 (en) | Compositions comprising anti-igf-1 receptor antibodies and methods for obtaining said antibodies | |
| MY161909A (en) | Anti-her3 antibodies and uses thereof | |
| TN2009000181A1 (en) | Agonist trkb antibodies and uses thereof | |
| EP2115494A4 (en) | METHOD AND APPARATUS FOR ANALYZING GEOLOGICAL CHARACTERISTICS | |
| WO2007120766A3 (en) | Erythropoietin receptor agonists | |
| IL206072A0 (en) | Novel method for generating and screening an antibody library | |
| WO2009024771A3 (en) | Materials and methods for treating cancers which express folate receptors | |
| EP2136337A4 (en) | DEVICE, METHOD AND PROGRAM FOR CREATING AN ALBUMS | |
| EP2084892A4 (en) | SYSTEM AND METHOD FOR SELECTING TONE MONITORING | |
| EP1999854A4 (en) | METHOD AND DEVICE FOR RESOURCE SELECTION BY MEANS OF KNOWN DATA TRANSFER | |
| WO2011103049A3 (en) | Method for screening receptors/ligands interactions | |
| SG157312A1 (en) | High affinity binding site of hgfr and methods for identification of antagonists thereof | |
| WO2010009856A3 (en) | Goodpasture antigen binding protein and its detection | |
| EP2010569A4 (en) | HUMAN ANTIBODIES SPECIFIC TO GASTRINE MATERIALS AND METHODS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |